SCOPUS 정보 검색 플랫폼

Clinical Pharmacology and Therapeutics

Volumn 96, Issue 2, 2014, Pages 138-140

CYP2D6 genotype and adjuvant tamoxifen

(1) Berry, D A a

a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TAMOXIFEN;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CLINICAL DECISION MAKING; CYP2D6 GENE; DISEASE FREE SURVIVAL; GENE; GENOTYPE; HUMAN; PRIORITY JOURNAL; REVIEW;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CYTOCHROME P-450 CYP2D6; FEMALE; HUMANS; TAMOXIFEN;

EID: 84904794997 PISSN: 00099236 EISSN: 15326535 Source Type: Journal
DOI: 10.1038/clpt.2014.96 Document Type: Review

Times cited : (11)

References (10)

1
- 84893732936
- Cyp2d6 genotype and adjuvant tamoxifen: Meta-Analysis of heterogeneous study populations
- Province, M.A. et al. CYP2D6 genotype and adjuvant tamoxifen: Meta-Analysis of heterogeneous study populations. Clin. Pharmacol. Ther. 95, 216-227 (2014
- (2014) Clin. Pharmacol. Ther , vol.95 , pp. 216-227
- Province, M.A.¹

2
- 84864955493
- Multiplicities in cancer research: Ubiquitous and necessary evils
- Berry, D.A. Multiplicities in cancer research: Ubiquitous and necessary evils. J. Natl. Cancer Inst. 104, 1125-1133 (2012
- (2012) J. Natl. Cancer Inst , vol.104 , pp. 1125-1133
- Berry, D.A.¹

3
- 33846563409
- Why most published research findings are false
- Ioannidis, J.P.A. Why most published research findings are false. PLoS Med. 2, e124 (2005
- (2005) PLoS Med , vol.2
- Ioannidis, J.P.A.¹

4
- 79952522792
- 13 December 2010
- Lehrer, J. The truth wears off. The New Yorker http: //www.newyorker.com/ reporting/2010/12/13/101213fa-fact-lehrer (13 December 2010
- The truth wears off. The New Yorker
- Lehrer, J.¹

5
- 84859169880
- Drug development: Raise standards for preclinical cancer research
- Begley, C.G. & Ellis, L.M. Drug development: Raise standards for preclinical cancer research. Nature 483, 531-533 (2012
- (2012) Nature , vol.483 , pp. 531-533
- Begley, C.G.¹ Ellis, L.M.²

6
- 84904788791
- 19 October 2013
- Unreliable research: Trouble at the lab. The Economist http: //www.economist.com/ news/briefing/21588057-scientists-Thinkscience-self- correcting-Alarming-degree-itnot-Trouble (19 October 2013
- Unreliable research: Trouble at the lab The Economist

7
- 0037811740
- Randomized trial of 2 versus 5 years of adjuvant tamoxifen for women aged 50 years or older with early breast cancer: Italian Interdisciplinary Group for Cancer Evaluation Study of Adjuvant Treatment in Breast Cancer 01
- DOI 10.1200/JCO.2003.06.116
- Sacco, M. et al. Randomized trial of 2 versus 5 years of adjuvant tamoxifen for women aged 50 years or older with early breast cancer: Italian Interdisciplinary Group for Cancer Evaluation Study of Adjuvant Treatment in Breast Cancer 01. J. Clin. Oncol. 21, 2276-2281 (2003 (Pubitemid 46621863)
- (2003) Journal of Clinical Oncology , vol.21 , Issue.12 , pp. 2276-2281
- Sacco, M.¹ Valentini, M.² Belfiglio, M.³ Pellegrini, F.⁴ De Berardis, G.⁵ Franciosi, M.⁶ Nicolucci, A.⁷

8
- 84884494850
- Cyp2d6 genotyping and the use of tamoxifen in breast cancer
- Berry, D.A. CYP2D6 genotyping and the use of tamoxifen in breast cancer. J. Natl. Cancer Inst. 105, 1267-1269 (2013
- (2013) J. Natl. Cancer Inst , vol.105 , pp. 1267-1269
- Berry, D.A.¹

9
- 84905166466
- Re: Concordance between cyp2d6 genotypes obtained from tumorderived and germline dna
- e-pub ahead of print 3 April 2014
- Goetz, M.P. et al. Re: Concordance between CYP2D6 genotypes obtained from tumorderived and germline DNA. J. Natl. Cancer Inst. (2014), e-pub ahead of print 3 April 2014
- (2014) J. Natl. Cancer Inst
- Goetz, M.P.¹

10
- 85015960246
- e-pub ahead of print 3 April 2014
- Berry, D.A. Response. J. Natl. Cancer Inst. (2014), e-pub ahead of print 3 April 2014.
- (2014) Natl. Cancer Inst
- Berry, D.A.¹ Response, J.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.